0 201

Cited 0 times in

Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial

DC Field Value Language
dc.contributor.author정현철-
dc.date.accessioned2023-06-02T01:05:10Z-
dc.date.available2023-06-02T01:05:10Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194638-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorZev A. Wainberg-
dc.contributor.googleauthorKohei Shitara-
dc.contributor.googleauthorEric Van Cutsem-
dc.contributor.googleauthorLucjan Wyrwicz-
dc.contributor.googleauthorKeun Wook Lee-
dc.contributor.googleauthorIveta Kudaba-
dc.contributor.googleauthorMarcelo Garrido-
dc.contributor.googleauthorHyun Cheol Cheol Chung-
dc.contributor.googleauthorJeeyun Lee-
dc.contributor.googleauthorHugo Raul Castro-Salguero-
dc.contributor.googleauthorWasat Mansoor-
dc.contributor.googleauthorMaria Ignez Braghiroli-
dc.contributor.googleauthorNina Karaseva-
dc.contributor.googleauthorEray Goekkurt-
dc.contributor.googleauthorHironaga Satake-
dc.contributor.googleauthorJoseph Chao-
dc.contributor.googleauthorUma Kher-
dc.contributor.googleauthorSukrut Shah-
dc.contributor.googleauthorPooja Bhagia-
dc.contributor.googleauthorJosep Tabernero-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.243-
dc.contributor.localIdA03773-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.243-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.affiliatedAuthor정현철-
dc.citation.volume40-
dc.citation.number4 suppl-
dc.citation.startPage243-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 243, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.